HSPB1 and ovarian carcinoma: Collectively, these results demonstrate that cisplatin induces ROS and ferroptosis, and HSP27 knockdown further increases cisplatin-induced ROS in A2780CIS and PEO4 cisplatin-resistant ovarian cancer cells.